{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:29:29Z","timestamp":1791181769276,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.drudis.2010.05.011","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T01:57:38Z","timestamp":1275443858000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["P2Y nucleotide receptors: promise of therapeutic applications"],"prefix":"10.1016","volume":"15","author":[{"given":"Kenneth A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Boeynaems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2010.05.011_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nm1617","article-title":"Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells","volume":"13","author":"Idzko","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2010.05.011_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2005-869519","article-title":"Overview of P2 receptors","volume":"31","author":"Boeynaems","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.drudis.2010.05.011_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/mol.64.4.785","article-title":"Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules","volume":"64","author":"Lazarowski","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2010.05.011_bib6","doi-asserted-by":"crossref","first-page":"16561","DOI":"10.1074\/jbc.M009609200","article-title":"Cotranscription and intergenic splicing of human P2Y11 and SSF1 genes","volume":"276","author":"Communi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-006-9054-2","article-title":"Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling","volume":"20","author":"Ivanov","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.drudis.2010.05.011_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.109.156687","article-title":"Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor","volume":"331","author":"Hoffmann","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2010.05.011_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20061728","article-title":"Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis","volume":"405","author":"Zylberg","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2010.05.011_bib10","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1074\/jbc.270.9.4185","article-title":"Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity","volume":"270","author":"Erb","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(02)00038-X","article-title":"Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family","volume":"24","author":"Abbracchio","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2010.05.011_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nm1188","article-title":"Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor","volume":"11","author":"Jankowski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1073\/pnas.89.6.2370","article-title":"Analogues of diadenosine 5,5-P1,P4-tetraphosphate (Ap4A) as potential anti-platelet aggregation agents","volume":"89","author":"Zamecnik","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2010.05.011_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11302-005-0648-2","article-title":"Structure\u2013activity relationships of dinucleotides: potent and selective agonists of P2Y receptors","volume":"1","author":"Shaver","year":"2005","journal-title":"Purinerg. Sig."},{"key":"10.1016\/j.drudis.2010.05.011_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/092986706775476052","article-title":"P2 receptors activated by uracil nucleotides \u2013 an update","volume":"13","author":"Brunschweiger","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1538-7836.2006.01866.x","article-title":"(N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets","volume":"4","author":"Bourdon","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2010.05.011_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/jm060903o","article-title":"Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2\u2032-amino-2\u2032-deoxy-2-thio-UTP","volume":"50","author":"Ivanov","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib18","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1074\/jbc.M410764200","article-title":"P2Y6 nucleotide receptors activate NF-\u03baB and increase survival of osteoclasts","volume":"280","author":"Korcok","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib19","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/jm061222w","article-title":"Structure activity relationship of uridine 5\u2032-diphosphoglucose (UDP-glucose) analogues as agonists of the human P2Y14 receptor","volume":"50","author":"Ko","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib20","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.bmcl.2008.04.028","article-title":"P2Y1 receptor antagonists as novel antithrombotic agents","volume":"18","author":"Pfefferkorn","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2010.05.011_bib21","unstructured":"Kindon, N. et al. (1998) Novel compounds. WO\/1998\/054180."},{"key":"10.1016\/j.drudis.2010.05.011_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.bcp.2004.01.011","article-title":"Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors","volume":"67","author":"Mamedova","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib23","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1021\/jm050301p","article-title":"Synthesis and structure\u2013activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency","volume":"48","author":"Ullmann","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1160\/TH06-12-0732","article-title":"A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models","volume":"97","author":"Wang","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2010.05.011_bib25","article-title":"Initial intravenous experience with PRT060128 (PRT128), an orally available, direct-acting, and reversible P2Y12 inhibitor","volume":"5","author":"Lieu","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drudis.2010.05.011_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2005.04.021","article-title":"Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor","volume":"70","author":"Kim","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"#cr-split#-10.1016\/j.drudis.2010.05.011_bib27.1","unstructured":"(a) Belley, M. et al. (2009) Substituted 2-naphthoic acids as antagonists of GPR105 activity. WO 2009\/070873A1."},{"key":"#cr-split#-10.1016\/j.drudis.2010.05.011_bib27.2","unstructured":"(b) Guay, D. et al. (2009) Substituted fused pyrimidines as antagonists of GPR105 activity. WO 2009\/000087."},{"key":"10.1016\/j.drudis.2010.05.011_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/jm970433l","article-title":"Deoxyadenosine-bisphosphate derivatives as potent antagonists at P2Y1 receptors","volume":"41","author":"Camaioni","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0026-895X(25)09561-6","article-title":"Identification of competitive antagonists of the P2Y1-receptor","volume":"50","author":"Boyer","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib30","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1021\/jm030127+","article-title":"2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a Northern conformation: enhanced potency as P2Y1 receptor antagonists","volume":"46","author":"Kim","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706453","article-title":"[32P]2-iodo-N6-methyl-(N)-methanocarba-2\u0301-deoxyadenosine-3\u2032,5\u2032-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors","volume":"147","author":"Houston","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib32","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/jm0700971","article-title":"P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring","volume":"50","author":"Costanzi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib33_1","first-page":"S18","article-title":"Hydrolytically stable and selective P2Y1\/6 receptor agonists","volume":"4","author":"Fischer","year":"2008","journal-title":"Purinerg. Sig."},{"key":"10.1016\/j.drudis.2010.05.011_bib33_2","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1021\/jm020251d","article-title":"Adenosine 5\u2032-O-(1-boranotriphosphate) derivatives as novel P2Y1 receptor agonists","volume":"45","author":"Nahum","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib34","unstructured":"Herpin, T.F. et al. (2005) Aminobenzazoles as P2Y1 receptors inhibitors. WO2005070920."},{"key":"10.1016\/j.drudis.2010.05.011_bib35","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1016\/j.bmcl.2008.09.102","article-title":"Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists","volume":"18","author":"Morales-Ramos","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2010.05.011_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bmcl.2006.10.038","article-title":"Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP","volume":"17","author":"Davenport","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2010.05.011_bib37","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.bmc.2009.05.062","article-title":"Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y2 receptor antagonists","volume":"17","author":"Sauer","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bcp.2005.11.010","article-title":"Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5\u2032-triphosphate analogues at the human P2Y2 and P2Y4 receptors","volume":"71","author":"Jacobson","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib39","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2010.05.011_bib40","doi-asserted-by":"crossref","first-page":"31061","DOI":"10.1074\/jbc.M003255200","article-title":"Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations","volume":"275","author":"Lazarowski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib41","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1021\/jm060485n","article-title":"Structure activity relationship of uridine 5\u2032-diphosphate analogues at the human P2Y6 receptor","volume":"49","author":"Besada","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib42","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1021\/jm060848j","article-title":"Synthesis and structure\u2013activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors","volume":"49","author":"El-Tayeb","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib43","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1021\/jm050911p","article-title":"Human P2Y6 receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference","volume":"48","author":"Costanzi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/jm901432g","article-title":"Human P2Y14 receptor agonists: truncation of the hexose moiety of uridine-5\u2032-diphosphoglucose and its replacement with alkyl and aryl groups","volume":"53","author":"Das","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjp.0702909","article-title":"Pharmacological characterization of the human P2Y11 receptor","volume":"128","author":"Communi","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib46","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1021\/jm050301p","article-title":"Synthesis and structure\u2013activity relationships of suramin-derived P2Y11 receptor antagonist with nanomolar potency","volume":"48","author":"Ullmann","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.109.157750","volume":"332","author":"Meis","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2010.05.011_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ncpcardio1372","article-title":"Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future","volume":"5","author":"Raju","year":"2008","journal-title":"Nat. Clin. Pract."},{"key":"10.1016\/j.drudis.2010.05.011_bib49","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib50","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1073\/pnas.0510446103","article-title":"The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts","volume":"103","author":"Savi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2010.05.011_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/13543784.16.2.225","article-title":"AZD6140","volume":"16","author":"Tantry","year":"2007","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2010.05.011_bib52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib53","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/jm901518t","article-title":"Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation","volume":"53","author":"Parlow","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib54","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0960-894X(01)00313-4","article-title":"Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y12)","volume":"11","author":"Scarborough","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2010.05.011_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1160\/TH06-12-0732","article-title":"A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog model","volume":"97","author":"Wang","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.drudis.2010.05.011_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y12 inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2010.05.011_bib57","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2010.05.011_bib58","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1124\/dmd.109.028498","article-title":"A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel","volume":"37","author":"Hagihara","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drudis.2010.05.011_bib59","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib60","first-page":"340","article-title":"Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events","volume":"11","author":"Oestreich","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2010.05.011_bib61","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.coph.2009.02.004","article-title":"Purinergic receptors in airway epithelia","volume":"9","author":"Lazarowski","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/13543784.13.1.47","article-title":"Diquafosol tetrasodium: a novel dry eye therapy","volume":"13","author":"Nichols","year":"2004","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2010.05.011_bib63","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2010.05.011_bib64","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8399","article-title":"Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice","volume":"104","author":"L\u00e9on","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2010.05.011_bib65","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2010.05.011_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.105.094037","article-title":"MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032,5\u2032-bisphosphate], a potent, selective and stable antagonist of the P2Y1 receptor, with strong antithrombotic activity in mice","volume":"316","author":"Hechler","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2010.05.011_bib67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1124\/mol.63.4.777","article-title":"Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice","volume":"63","author":"Robaye","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.bjp.0706353","article-title":"The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion","volume":"146","author":"Ghanem","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/14656560802631319","article-title":"Lubiprostone: chronic constipation and irritable bowel syndrome with constipation","volume":"10","author":"Lacy","year":"2009","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.drudis.2010.05.011_bib70","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.108.788927","article-title":"Reduced atherosclerotic lesions in P2Y1\/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors","volume":"118","author":"Hechler","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2010.05.011_bib71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1124\/mol.108.046904","article-title":"Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells","volume":"74","author":"Bar","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib72","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1476-5381.2009.00497.x","article-title":"P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice","volume":"159","author":"Guns","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2010.05.011_bib74","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s00018-005-5194-0","article-title":"The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis","volume":"62","author":"Jacquet","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drudis.2010.05.011_bib75","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.RES.0000217402.73402.cd","article-title":"Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction","volume":"98","author":"Wihlborg","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2010.05.011_bib76","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1038\/emboj.2008.237","article-title":"P2Y6 receptor-Galpha12\/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis","volume":"27","author":"Nishida","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2010.05.011_bib77","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2006.07.019","article-title":"Uridine-5\u2032-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct","volume":"72","author":"Yitzhaki","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2010.05.011_bib78","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1132559","article-title":"ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.drudis.2010.05.011_bib79","doi-asserted-by":"crossref","first-page":"24960","DOI":"10.1074\/jbc.M301439200","article-title":"The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells","volume":"278","author":"Seye","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jcp.20979","article-title":"Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte-derived dendritic cells","volume":"211","author":"Marcet","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drudis.2010.05.011_bib81","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.M102568200","article-title":"P2Y6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide","volume":"276","author":"Warny","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2010.05.011_bib82","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.4049\/jimmunol.166.12.7172","article-title":"The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells","volume":"166","author":"Wilkin","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2010.05.011_bib83","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.166.3.1611","article-title":"Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses","volume":"166","author":"la Sala","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2010.05.011_bib84","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria T(H)17 cell differentiation","volume":"455","author":"Atarashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2010.05.011_bib85","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1182\/blood-2004-05-1718","article-title":"Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway","volume":"105","author":"Schnurr","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2010.05.011_bib86","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2010.05.011_bib87","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP acting at P2Y6 receptors is a novel mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2010.05.011_bib88","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1523\/JNEUROSCI.0323-08.2008","article-title":"P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury","volume":"28","author":"Tozaki-Saitoh","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2010.05.011_bib89","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1523\/JNEUROSCI.5589-07.2008","article-title":"P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain","volume":"28","author":"Kobayashi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2010.05.011_bib90","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/cvr\/cvp265","article-title":"NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse","volume":"85","author":"Kauffenstein","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.drudis.2010.05.011_bib91","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/mol.109.058578","article-title":"Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor","volume":"76","author":"Carter","year":"2009","journal-title":"Mol. Pharmacol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644610001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644610001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:06:11Z","timestamp":1761221171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644610001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":93,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1359644610001807"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2010.05.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y nucleotide receptors: promise of therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2010.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}